天津中医药2016，Vol.33Issue(6)：339-342,4.DOI:10.11656/j.issn.1672-1519.2016.06.06
右美托咪定用于慢性阻塞性肺疾病急性加重期肺肾两虚型患者无创辅助通气镇静的临床观察
Clinical observation on dexmedetomidine for chronic obstructive pulmonary disease with acute exacerbation of lung and kidney deficiency type two patients with of noninvasive ventilation sedation
孔令宜 1李桂伟1
作者信息
- 1. 天津中医药大学第一附属医院ICU，天津 300193
- 折叠
摘要
Abstract
[Objective] To observe the effects of dexmedetomidine for noninvasive ventilation in chronic obstructive pulmonary disease with acute exacerbation (AECOPD) clinical efficacy and safety of lung and kidney deficiency type two patients with sedative. [Methods] To select in the past two years in our hospital intensive care unit (ICU) from 64 cases of noninvasive ventilation in AECOPD patients, they were randomly divided into observation group and control group, each group has 32 cases, all cases were in AECOPD latest guide in based on the routine treatment taking bronchiectasis agent, systemic corticosteroids and antibiotics and other drugs. All the patients were treated with noninvasive ventilatory support, also given to the observation group patients with dexmedetomidine sedation. [Results] Dexmedetomidine set in the observation group, the clinical therapeutic effect of overall was better than the control group and better patient compliance, more comfort and reduce the chances of a cannula, shortens the time machine, shorten the ICU hospitalization time. [Conclusion] Dexmedetomidine set has good clinical efficacy and safety, sedative effect, as in patients with AECOPD noninvasive assisted ventilation calm when the first choice of the drugs.关键词
右美托咪定/AECOPD/无创辅助通气/镇静Key words
dexmedetomidine/AECOPD/noninvasive ventilation/sedative effect分类
医药卫生引用本文复制引用
孔令宜,李桂伟..右美托咪定用于慢性阻塞性肺疾病急性加重期肺肾两虚型患者无创辅助通气镇静的临床观察[J].天津中医药,2016,33(6):339-342,4.
